Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Debt Ratio (2010 - 2025)

Updated

Sinovac Biotech's (SVA) Debt Ratio stood at 0.06 in Q4 2025, up 90.2% from 0.03 a year earlier.

Analysis

Sinovac Biotech (SVA) Debt Ratio (2010 - 2025) Analysis & Trends

Starting with Q4 2010, Sinovac Biotech's Debt Ratio history includes 16 quarters.

  • Across earlier years, Debt Ratio came in at 0.03 in FY2024 (+63.3%), 0.02 in FY2023, 0.00 in FY2022 (-10.6%) and 0.00 in FY2021 (-94.9%).
  • The Q4 2025 figure is the highest quarterly Debt Ratio since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 0.39
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 0.23
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 0.52
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 0.42
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 0.08
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 0.28
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 0.60
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 0.53
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 0.31
10 Sinovac Biotech 464.94 Mn -35.05 Bn - 0.06
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.06
Dec 31, 2024 0.03
Dec 31, 2023 0.02
Dec 31, 2022 0.00
Dec 31, 2021 0.00
Dec 31, 2020 0.02
Dec 31, 2019 0.01
Dec 31, 2018 0.02
Dec 31, 2017 0.11
Dec 31, 2016 0.19
Dec 31, 2015 0.11
Dec 31, 2014 0.21
Dec 31, 2013 0.20
Dec 31, 2012 0.17
Dec 31, 2011 0.10
Dec 31, 2010 0.10
API Access

Sinovac Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SVA&period=max&api_key=YOUR_API_KEY